Benzoxazinones as potent positive allosteric AMPA receptor modulators: Part I
Authors:
- Rudolf MuellerRMRudolf Mueller
- Yong-Xin LiYLYong-Xin Li
- Aidan HampsonAHAidan Hampson
- Sheng ZhongSZSheng Zhong
- Clayton HarrisCHClayton Harris
- Christopher MarrsCMChristopher Marrs
- Stanislaw RachwalSRStanislaw Rachwal
- Jolanta UlasJUJolanta Ulas
- Lena NielssonLNLena Nielsson
- Gary RogersGRGary Rogers
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (13) , 3923-3926
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Emerging role of glutamate in the pathophysiology of major depressive disorderBrain Research Reviews, 2009
- Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulationExperimental Neurology, 2008
- Prediction of the binding mode of biarylpropylsulfonamide allosteric AMPA receptor modulators based on docking, GRID molecular interaction fields and 3D-QSAR analysisJournal of Molecular Graphics and Modelling, 2008
- Identification of a putative binding site for 5-alkyl-benzothiadiazides in the AMPA receptor dimer interfaceJournal of Molecular Graphics and Modelling, 2007
- Pharmacology of Ampakine Modulators: From AMPA Receptors to Synapses and BehaviorCurrent Drug Targets, 2007
- A role for AMPA receptors in mood disordersBiochemical Pharmacology, 2006
- Therapeutic Potential of Positive AMPA Receptor Modulators in the Treatment of Neuropsychiatric DisordersCNS Drugs, 2006
- Mechanism of Positive Allosteric Modulators Acting on AMPA ReceptorsThe Journal of Neuroscience, 2005
- Mechanism of glutamate receptor desensitizationNature, 2002
- Benzamide-Type AMPA Receptor Modulators Form Two Subfamilies with Distinct Modes of ActionThe Journal of Pharmacology and Experimental Therapeutics, 2002